This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday – Expand Energy (NASDAQ:EXE), Catalyst Pharmaceuticals (NASDAQ:CPRX)

Feb 4, 2025
this-expand-energy-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-tuesday-–-expand-energy-(nasdaq:exe),-catalyst-pharmaceuticals-(nasdaq:cprx)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Baird analyst Joel Beatty initiated coverage on Catalyst Pharmaceuticals, Inc CPRX with an Outperform rating and announced a price target of $28. Catalyst Pharmaceuticals shares closed at $22.62 on Monday. See how other analysts view this stock.
  • Raymond James analyst John Freeman initiated coverage on Expand Energy Corporation EXE with a Strong Buy rating and announced a price target of $135. Expand Energy shares closed at $102.87 on Monday. See how other analysts view this stock.
  • BMO Capital analyst John Kim initiated coverage on Terreno Realty Corporation TRNO with a Market Perform rating and announced a price target of $71. Terreno Realty shares closed at $65.26 on Monday. See how other analysts view this stock.
  • Wolfe Research analyst Andy Chen initiated coverage on Vera Therapeutics, Inc. VERA with an Outperform rating and announced a price target of $49. Vera Therapeutics shares closed at $36.54 on Monday. See how other analysts view this stock.
  • Wolfe Research analyst Andy Chen initiated coverage on Oruka Therapeutics, Inc. ORKA with an Outperform rating and announced a price target of $20. Oruka Therapeutics shares closed at $13.70 on Monday. See how other analysts view this stock.

Considering buying EXE stock? Here’s what analysts think:

Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Leave a comment